Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events

BACKGROUND: The primary goal of phase 2 and 3 clinical trials is to evaluate the safety and effectiveness of therapeutic interventions, and efficient and reproducible ascertainment of important clinical events, either as clinical outcome events (COEs) or adverse events (AEs), is critical. Clinical o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Trials
Main Authors: Fanaroff, Alexander C., Haque, Ghazala, Thomas, Betsy, Stone, Allegra E., Perkins, Lynn M., Wilson, Matthew, Jones, W. Schuyler, Melloni, Chiara, Mahaffey, Kenneth W., Alexander, Karen P., Lopes, Renato D.
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2020
Fag:
Commentary
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7147037/
https://ncbi.nlm.nih.gov/pubmed/32272961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04254-w
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker